Actively Recruiting
Randomized Study to Assess Safety and Effectiveness of IN-115314 Ointment in Adults with Mild to Moderate Atopic Dermatitis
Led by HK inno.N Corporation · Updated on 2026-09-09
162
Participants Needed
1
Research Sites
11 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the effects of IN-115314 ointment in adults with mild to moderate atopic dermatitis. This phase 2 clinical trial aims to assess both how well the ointment works and how safe it is. The study compares two strengths of the ointment, 1% and 3%, against a placebo while monitoring skin condition changes using a standardized severity index. Participants will apply the assigned ointment twice daily for up to 56 days. The study includes three groups one using 1% ointment, another using 3% ointment, and a placebo group that applies placebo ointment for 28 days followed by 3% ointment for another 28 days. This approach helps evaluate the ointments effects over time and its pharmacokinetic properties. Throughout the study, participants will be regularly assessed for changes in their eczema severity using the Eczema Area and Severity Index EASI at 1, 2, and 4 weeks. Safety and side effects will also be closely monitored. The entire study period extends up to about two months, providing detailed information on treatment response and safety in adults with atopic dermatitis.
CONDITIONS
Brief Title
A Study to Evaluate the Efficacy and Safety of IN-115314 Ointment in Mild to Moderate Atopic Dermatitis Adult Patients
Research Team
H
Haerim Jang
Y
Yugyeong Park
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here